Vladimir Beljanski, Ph.D.
Affiliations: | 2004 | Emory University, Atlanta, GA |
Area:
physical and synthetic chemistryGoogle:
"Vladimir Beljanski"Parents
Sign in to add mentor| Luigi Marzilli | grad student | 2004 | Emory | |
| (Biological and biomolecular interactions of crosslinking agents and cisplatin analogs.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rossi F, Josey B, Sayitoglu EC, et al. (2020) Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells. Plos One. 15: e0239238 |
| Rossi F, Noren H, Sarria L, et al. (2019) Combination therapies enhance immunoregulatory properties of MIAMI cells. Stem Cell Research & Therapy. 10: 395 |
| Beljanski V, Grinnemo KH, Österholm C. (2019) Pleiotropic roles of autophagy in stem cell-based therapies. Cytotherapy |
| Olagnier D, Lababidi RR, Hadj SB, et al. (2017) Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Beljanski V, Chiang C, Hiscott J. (2015) The intersection between viral oncolysis, drug resistance, and autophagy. Biological Chemistry. 396: 1269-80 |
| Chiang C, Beljanski V, Yin K, et al. (2015) Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. Journal of Virology. 89: 8011-25 |
| Hiscott J, Chiang C, Beljanski V. (2015) ID: 258 Cytokine. 76: 111 |
| Olagnier D, Peri S, Steel C, et al. (2014) Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. Plos Pathogens. 10: e1004566 |
| Shulak L, Beljanski V, Chiang C, et al. (2014) Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy. Journal of Virology. 88: 2927-40 |
| Samuel S, Beljanski V, Van Grevenynghe J, et al. (2013) BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1413-23 |